Answers are grounded in this paper and cite their sources.
Previous studies have suggested that low 25-hydroxyvitamin D (25[OH]D) levels are associated with diabetes mellitus, hypertension, and cancers. Low levels are also associated with all-cause mortality in hemodialysis patients. Although there is a reduced risk of all-cause mortality in incident dialysis patients treated with vitamin D agents, including calcitriol and activated vitamin D3, no published studies have evaluated the risk of mortality in the general population. To test the association of low 25(OH)D levels with all-cause cancer, and cardiovascular disease (CVD) mortality, the authors analyzed the data from the Third National Health and Nutrition Examination Survey (NHANES III)-linked mortality files for 13,331 adults 20 years or older. Patient mortality rates were assessed from 1988 through 1994, with a median 8.7 years of follow-up. In multivariate logistic regression analyses, independent predictors of 25(OH)D deficiency were defined as being in the lowest quartile 25(OH)D levels ≤17.8 ng/ml. Independent risk factors associated with higher odds of 25(OH)D deficiency (≤17.8 ng/ml) were increasing age, female sex, nonwhite race/ethnicity, diabetes, higher body mass index, and current smoking. Decreased odds of deficiency were associated with vitamin D supplementation, physical activity, and nonwinter season. During the median 8.7 years of follow-up, 1806 deaths were recorded, including 777 from CVD. The all-cause mortality rate was adjusted in multivariate models for baseline demographics, season, and traditional and novel CVD risk factors. Compared with the highest quartile, the lowest quartile (25[OH]D levels <17.8 ng/ml) was associated with a 26% increased rate of all-cause mortality (mortality rate ratio,1.26; 95% confidence interval [CI], 1.08–1.46) and a population attributable risk of 3.1%. There was a higher, although statistically insignificant, risk of CVD and cancer mortality. No association was found for other causes of death. These data show that low levels of 25(OH)D (≤17.8 ng/ml) are associated with a higher risk of all-cause mortality in the general US population. To the authors’ knowledge, this is the first study to evaluate this association.
No takes yet. Share an insight, caveat, or question.
Melamed et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: